tirzepatide first month weight loss average Our management program: 12 months of semaglutide, 7 months of Average Monthly Weight Loss on

Rooted in trusted primary care relationships, our program combines clinical oversight with lifestyle supportdriving behavior change before, during, and after GLP-1 use

Presented for research literature review only Kano SI et al

Compared to controls, patients with GLP-1RAs have a 14% lower risk of respiratory disease (RR 0.86, 95% CI 0.810.93 p 0 0.05

After stopping, your body does not immediately reverse this adaptation, meaning you burn fewer calories at rest even as your hunger increasesa double disadvantage

however, their efficacies vary, particularly in patients with COPD compared to those with asthma [76]